Among these conditions, retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are particularly prevalent. Recent advancements in gene therapy have opened new avenues for treating ...

Researchers at Johns Hopkins and their collaborators conducted an open-label phase I clinical trial of a new treatment, in which a viral vector expressing the gene for sFLT01, a protein that ...

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

BENGALURU: Bengaluru-based Narayana Nethralaya is developing gene therapy solutions that could drastically reduce the cost of ...

Janet Osborne hopes to continue gardening if her sight loss is halted A woman from Oxford has become the first person in the world to have gene therapy to try to halt the most common form of ...

Scientists from Trinity College Dublin have developed a highly promising gene therapy ... shown that their therapy offered promise in treating dry age-related macular degeneration (AMD).

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

And just last week, researchers reported that a retinal implant allowed a 69-year-old woman with macular degeneration to more than double the number of letters she could identify on a vision chart.

In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses recent breakthroughs demonstrating that gene ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Wet macular degeneration accounts for the remaining ... However, research into innovative therapies such as stem cell therapy, gene therapy, and implantable retinal devices offers hope for the ...